Choice of Sclerosant: An Experimental Study

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The sclerosant hydroxypolyethoxydodecan (HPD) was studied in rats, and the results were compared with those from a previous study of tetradecyl sulphate of sodium (TSS). There appeared to be no significant difference between the two. The sclerosant efficiency increased with increasing concentration up to 6%, but a higher concentration than 6% is unlikely to be more effective in the rat or in man. In man, good results probably depend on exposure of the endothelium to sclerosant undiluted with blood for 1 s, and the total volume of 6% HPD or 6% TSS injected at one visit should not exceed 10 ml.

Related collections

Author and article information

Journal

Journal ID (publisher-id): JVR

Journal ID (nlm-ta): J Vasc Res

Journal ID (doi): 10.1159/issn.1018-1172

Title: Journal of Vascular Research

Publisher: S. Karger AG

ISSN (Print): 1018-1172

ISSN (Electronic): 1423-0135

Publication date Subscription-year: 1970

Publication date (Print): 1970

Publication date (Electronic): 18 September 2008

Volume: 7

Issue: 3

Pages: 182-186

Affiliations

Department of Pathology, St. Mary’s Hospital Medical School, London

Article

Publisher ID: 157833 Other ID: Angiologica 1970;7:182–186

DOI: 10.1159/000157833

SO-VID: 6641eaa1-7df2-4404-a64b-960caaba6301

License:

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Choice of Sclerosant: An Experimental Study

Read this article at

Abstract

Related collections

Karger: Cardiovascular System

Author and article information

Journal

Affiliations

Article

History

Page count

Categories

Comments

Comment on this article

Similar content 351